DT&CRO Co. Ltd.
DT&CRO CO., Ltd. operates as a full-service CRO provider in South Korea. The company conducts a series of consigned studies ranging from non-clinical GLP toxicity, PK, and efficacy tests required for licensing of pharmaceuticals, chemicals, health functional foods, cosmetics, and medical devices to analysis, bioactivity, clinical trials, and licensing consulting. DT&CRO CO., Ltd. was founded in 2… Read more
DT&CRO Co. Ltd. (383930) - Total Assets
Latest total assets as of September 2025: ₩87.30 Billion KRW
Based on the latest financial reports, DT&CRO Co. Ltd. (383930) holds total assets worth ₩87.30 Billion KRW as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
DT&CRO Co. Ltd. - Total Assets Trend (2021–2024)
This chart illustrates how DT&CRO Co. Ltd.’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
DT&CRO Co. Ltd. - Asset Composition Analysis
Current Asset Composition (December 2024)
DT&CRO Co. Ltd.'s total assets of ₩87.30 Billion consist of 23.7% current assets and 76.3% non-current assets.
| Asset Category | Amount (KRW) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩0.00 | 5.8% |
| Accounts Receivable | ₩13.00 Billion | 16.0% |
| Inventory | ₩787.02 Million | 1.0% |
| Property, Plant & Equipment | ₩52.18 Billion | 64.4% |
| Intangible Assets | ₩1.47 Billion | 1.8% |
| Goodwill | ₩0.00 | 0.0% |
Asset Composition Trend (2021–2024)
This chart illustrates how DT&CRO Co. Ltd.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: DT&CRO Co. Ltd.'s current assets represent 23.7% of total assets in 2024, a decrease from 52.8% in 2021.
- Cash Position: Cash and equivalents constituted 5.8% of total assets in 2024, down from 21.5% in 2021.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 1.0% of total assets, a decrease from 4.0% in 2021.
- Asset Diversification: The largest asset category is property, plant & equipment at 64.4% of total assets.
DT&CRO Co. Ltd. Competitors by Total Assets
Key competitors of DT&CRO Co. Ltd. based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
MedPacto Inc
KQ:235980
|
Korea | ₩51.58 Billion |
|
2H0
F:2H0
|
Germany | €15.27 Million |
|
Shenzhen CAU Technology Co Ltd
SHE:000004
|
China | CN¥260.55 Million |
|
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403
|
China | CN¥9.58 Billion |
|
Nanhua Bio Medicine Co Ltd
SHE:000504
|
China | CN¥841.96 Million |
|
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518
|
China | CN¥509.14 Million |
|
Chengzhi Shareholding Co Ltd
SHE:000990
|
China | CN¥27.52 Billion |
|
Hualan Biological EngineeringInc
SHE:002007
|
China | CN¥16.27 Billion |
DT&CRO Co. Ltd. - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - DT&CRO Co. Ltd. generates 0.44x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - DT&CRO Co. Ltd. is currently not profitable relative to its asset base.
DT&CRO Co. Ltd. - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.48 | 0.45 | 0.82 |
| Quick Ratio | 0.46 | 0.42 | 0.79 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | ₩-25.31 Billion | ₩ -22.17 Billion | ₩ -6.03 Billion |
DT&CRO Co. Ltd. - Advanced Valuation Insights
This section examines the relationship between DT&CRO Co. Ltd.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.47 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | 35.5% |
| Total Assets | ₩81.09 Billion |
| Market Capitalization | $17.45 Million USD |
Valuation Analysis
Below Book Valuation: The market values DT&CRO Co. Ltd.'s assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: DT&CRO Co. Ltd.'s assets grew by 35.5% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for DT&CRO Co. Ltd. (2021–2024)
The table below shows the annual total assets of DT&CRO Co. Ltd. from 2021 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | ₩81.09 Billion | +35.49% |
| 2023-12-31 | ₩59.85 Billion | -7.26% |
| 2022-12-31 | ₩64.53 Billion | +96.23% |
| 2021-12-31 | ₩32.89 Billion | -- |